Showing results (11-20 of 38) with videos related to

Sort By:
Pageof 4
Cancers|November 25, 2023
Patient Characteristics Associated with Growth of Patient-Derived Tumor Implants in Mice (Patient-Derived Xenografts)Tatiana Hernández Guerrero, Natalia Baños, Laura Del Puerto Nevado, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 12, 2024
Eftilagimod Alpha (Soluble LAG3 Protein) Combined with Pembrolizumab as Second-Line Therapy for Patients with Metastatic Head and Neck Squamous Cell CarcinomaMartin Forster, Irene Brana, Antonio L Pousa, et al.
European Journal of Cancer (Oxford, England : 1990)|October 3, 2018
A phase 1b study of afatinib in combination with standard-dose cetuximab in patients with advanced solid tumoursAnas Gazzah, Valentina Boni, Jean-Charles Soria, et al.
JTO Clinical and Research Reports|October 15, 2024
Eftilagimod Alpha (a Soluble LAG-3 Protein) Combined With Pembrolizumab in Second-Line Metastatic NSCLC Refractory to Anti-Programmed Cell Death Protein 1/Programmed Death-Ligand 1-Based Therapy: Final Results from a Phase 2 StudyMatthew G Krebs, Martin Forster, Margarita Majem, et al.
The Oncologist|January 20, 2025
A first-in-human study of JNJ-70218902, a bispecific T-cell-redirecting antibody against TMEFF2 in metastatic castration-resistant prostate cancerEmiliano Calvo, Bernard Doger, Joan Carles, et al.
Clinical Epigenetics|July 9, 2026
Tumor-type specific methylation patterns of MTAP in human samples and cell linesLuis Álvarez-Carrión, Dalma Müller, Manuel Pedregal, et al.
Investigational New Drugs|March 11, 2021
Efficacy and safety of lurbinectedin and doxorubicin in relapsed small cell lung cancer. Results from an expansion cohort of a phase I studyMaría Eugenia Olmedo, Martin Forster, Victor Moreno, et al.
JCO Oncology Practice|July 25, 2025
Derivation and External Validation of Objective Performance Status Among Patients With Metastatic CancerEva Ruiz, Christopher R Manz, Anthony Girard, et al.
European Journal of Cancer (Oxford, England : 1990)|February 19, 2021
Phase I dose-escalation study of NBTXR3 activated by intensity-modulated radiation therapy in elderly patients with locally advanced squamous cell carcinoma of the oral cavity or oropharynxCaroline Hoffmann, Valentin Calugaru, Edith Borcoman, et al.
European Journal of Cancer (Oxford, England : 1990)|December 12, 2017
Neutrophil-lymphocyte ratio kinetics in patients with advanced solid tumours on phase I trials of PD-1/PD-L1 inhibitorsMalaka Ameratunga, Maxime Chénard-Poirier, Irene Moreno Candilejo, et al.
Pageof 4